뇌척수액(CSF) 관리 시장 규모 및 예측, 세계 및 지역별 점유율, 동향 및 성장 기회 분석 보고서 범위 : 제품별, 최종 사용자별, 지역별

Cerebrospinal Fluid Management Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography

US $ 4,450 ￦ 6,126,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 6,450 ￦ 8,879,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450 ￦ 11,633,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뇌척수액(CSF) 관리 시장 시장 규모는 2022년 19억 1,137만 달러에서 2030년 28억 9,254만 달러에 달할 것으로 예상되며, 2022-2030년간 5.3%의 CAGR을 나타낼 것으로 추정됩니다.

더 나은 치료 방법에 대한 수요가 증가함에 따라 지난 수십년동안 다양한 제품 개발이 이루어졌습니다. 다음은 최근 수액 관리 시장의 제품 개발 사례 중 몇 가지를 소개하고자 합니다.

2022년 9월, Anuncia Medical Inc.는 션트가 필요한 수두증 및 기타 뇌척수액 장애 환자를 치료하기 위해 미국 식품의약국(FDA)으로부터 ReFlow System Mini를 승인받았습니다. 카테터 플러싱을 촉진하고 션트 내 뇌척수액 유량을 회복, 증가 또는 유지합니다.

2021년 3월, FDA는 Anuncia의 수액 관리용 ReFlow 시스템에 획기적인 의료기기 지정을 부여했습니다. 이 장치는 션트가 필요한 수두증과 같은 수액 장애를 치료하기 위해 설계되었으며, ReFlow 시스템은 CSF의 막힘을 예방하기 위해 비침습적으로 수행되는 예방적 플러싱을 위해 가정 건강 관리 및 클리닉에서 사용할 수 있습니다.

2020년 6월, FDA는 Rhaeos, Inc.의 무선 비침습적 유량 센서 FlowSense에 혁신적 장치 지정을 부여했습니다. 이 제품은 수두증으로 인해 뇌척수액이 과다한 환자의 뇌실 션트 기능을 신속하게 모니터링할 수 있도록 설계됐습니다.

신경질환 치료에서 뇌척수액(CSF) 관리에 대한 관심이 높아지면서 뇌척수액(CSF) 관리 시장에 새로운 기회를 가져다 줄 것임

CSF 매개 변수는 성인 환자의 신경 질환의 바이오 마커로 널리 평가되고 있으며, CSF의 순환 마이크로 RNA는 다양한 신경 질환을 진단하는 데 유망한 바이오 마커입니다. 파킨슨병(PD), 알츠하이머병(AD), 간질, 경련과 같은 신경질환은 종종 CSF 매개변수를 변화시키는데, Nature에 게재된 논문에 따르면 PD 진단을 받은 환자에서 76종의 수액 단백질이 정상인에 비해 구조적으로 변화된 것으로 나타났습니다. 발견되었습니다. 이 연구는 또한 이러한 CSF 단백질이 질병의 진단 및 치료를위한 바이오 마커로 사용될 수 있음을 시사합니다. PD는인지 기능 장애와 운동 기능 저하를 동반 한 신경 퇴행성 질환입니다. 25년 동안 두 배로 증가해 세계 60세 이상 인구의 약 1%가 앓고 있습니다. 마찬가지로, 발작이나 간질 상태의 환자에서는 단백질이나 젖산 수치와 같은 수액 매개변수 중 일부가 변화합니다. 따라서 뇌척수액 파라미터를 발작 및 간질 치료에 활용하기 위한 다양한 연구 개발이 진행되고 있습니다. 또한, CSF를 이용한 알츠하이머병 검출을 위한 다양한 CSF 분석이 시중에 나와 있음에도 불구하고, 검출 및 치료 목적의 바이오마커에 대한 수요는 충족되지 않고 있습니다. 알츠하이머병 및 PD의 사례 발견이 증가함에 따라 수액 누출 사례가 증가 할 수 있기 때문에 수액 관리 장치에 대한 수요가 증가하고 있습니다. 따라서 신경 질환의 유병률 증가는 이러한 질환의 치료에 수액 관리 제품을 사용하기위한 연구 개발 활동에 박차를 가하고 있습니다.

뇌척수액(CSF) 관리 시장은 제품 및 최종 사용자로 구분됩니다. 제품별로는 뇌척수액 션트와 뇌척수액 배액 시스템으로 구분되며, 2022년에는 CSF 션트 부문이 제품별 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 제품 출시 증가, 고급 뇌척수액 션트에 대한 수요 증가, 수두증 발생 건수 증가로 인해 시장 추정 및 예측 기간 동안 에 상당한 CAGR로 성장할 것으로 예상됩니다. 뇌척수액 션트는 뇌실 션트, 뇌실 심방 션트, 뇌실 흉막 션트, 요복막 션트로 나뉩니다. 뇌척수액 션트를 기준으로 볼 때, 뇌실 복막 션트는 뇌척수액(CSF) 관리 시장에서 가장 큰 시장 점유율을 차지하고 있으며 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 마찬가지로 뇌척수액 배액 시스템은 뇌실외 배액(EVD) 시스템과 요추 배액(LD) 시스템으로 분류됐습니다. 뇌실외 배액 시스템은 업계에서 가장 일반적으로 사용되는 CSF 배액 시스템이기 때문에 이 분야에서 가장 큰 점유율을 차지하고 있습니다.

지역별로 보면 시장은 북미, 유럽, 아시아태평양 중동 및 아프리카, 중남미로 나뉩니다. 북미는 뇌척수액(CSF) 관리 시장에서 가장 큰 점유율을 차지하고 있습니다. 수두증, 외상성 뇌손상 및 기타 신경 질환의 발생 증가, 급속한 기술 혁신, 신흥 시장의 의료 인프라 구축 등으로 인해 북미 시장은 예측 기간 동안 우위를 유지할 것으로 예상됩니다. 반면, 아시아태평양은 노인 인구 증가, 첨단 의료기기에 대한 수요 증가, 효율적인 치료를 제공하는 의료 인프라 증가 등의 요인으로 인해 시장에서 가장 빠르게 성장하고 있는 지역입니다.

뇌척수액(CSF) 관리 시장의 성장은 뇌척수액 누출 발생 건수 증가와 뇌척수액(CSF) 관리 제품의 신흥국 시장 개척이 주요 요인으로 작용하고 있습니다. 반면, 뇌척수액 션트 관련 리스크는 시장 성장을 저해하는 요인으로 작용하고 있습니다.

캐나다 감염병 보고서(CCDR), 미국 질병예방통제센터(CDC), 유럽연합(EU), 이탈리아 무역청(ITA) 등은 뇌척수액(CSF) 관리 시장에 대한 보고서를 작성할 때 참고한 1차 및 이차 정보 중 일부입니다.

목차

제1장 서론

제2장 주요 요약

• 주요 인사이트

제3장 조사 방법

• 조사 범위
• 2차 조사
• 1차 조사

제4장 뇌척수액(CSF) 관리 시장 상황

• PEST 분석
  • 북미의 PEST 분석
  • 유럽의 PEST 분석
  • 아시아태평양의 PEST 분석
  • 중남미의 PEST 분석
  • 중동 및 아프리카 PEST 분석

제5장 뇌척수액(CSF) 관리 시장 - 주요 산업 역학

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 동향
• 영향 분석

제6장 뇌척수액(CSF) 관리 시장 - 세계 시장 분석

• 뇌척수액(CSF) 관리 시장 매출, 2022년-2030년

제7장 뇌척수액(CSF) 관리 세계 시장 - 2030년까지 매출과 예측 : 제품별

• 뇌척수액(CSF) 관리 시장 제품별 매출 점유율, 2022년 및 2030년(%)
• Lumboperitoneal Shunts
• Lumbar Drainage (LD) Systems

제8장 뇌척수액(CSF) 관리 세계 시장 - 최종사용자별 매출과 2030년까지 예측

• 뇌척수액(CSF) 관리 시장 최종사용자별 매출 점유율, 2022년 및 2030년(%)
• 병원
• 진료소
• 외래수술센터(ASC)
• 기타

제9장 뇌척수액(CSF) 관리 시장 : 지역별 분석

• 북미
  • 멕시코
• 유럽
  • 기타 유럽
• 아시아태평양
  • 기타 아시아태평양
• 중동 및 아프리카
  • 기타 중동 및 아프리카
• 중남미
  • 기타 중남미

제10장 COVID-19 전후의 영향

• COVID-19 전후의 영향

제11장 뇌척수액(CSF) 관리 시장 - 업계 상황

• 뇌척수액(CSF) 관리 시장 성장 전략, 2020-2023년
• 무기적 성장 전략
  • 무기적 성장 전략
• 유기적 성장 전략

제12장 기업 개요

• Medtronic Plc
• Integra LifeSciences Holdings Corp
• B. Braun SE
• Argi Group Health Services Ltd Sti
• Sophysa SA
• BeckerSmith Medical Inc
• Delta Surgical Ltd
• Moller Medical GmbH
• Natus Medical Inc
• Spiegelberg GmbH & Co KG

제13장 부록

LSH

영문 목차

영문목차

The cerebrospinal fluid management market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The growing demand for better treatment modalities has resulted in various product developments in the last few decades. A few of the examples of recent product developments in the CSF management market are mentioned below.

In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.

In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.

In June 2020, the FDA granted Breakthrough Device Designation to the FlowSense wireless, noninvasive flow sensor offered by Rhaeos, Inc. The product is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus.

Increasing Focus on CSF Management in Neurological Disease Treatments Provides New Opportunities for the Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

The cerebrospinal fluid management market is segments into product and end user. Based on product, the market is bifurcated into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus. CSF shunts was further segmented into ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts. Based on CSF shunts, ventriculoperitoneal shunts held the largest market share of cerebrospinal fluid management market and is expected to grow at a fastest CAGR during the forecast period. Similarly, the CSF drainage systems were classified into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. External ventricular drainage systems are the more commonly used CSF drainage systems in the industry therefore, marking largest share of the segment.

Based on geography, the market is segmented into North America, Europe, Asia Pacific Middle East & Africa, and South & Central America. North America held the largest market share of the cerebrospinal fluid management market. The market in North America is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure. Whereas Asia Pacific is the fastest growing region in the market owing to the factors, including growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

The growth of cerebrospinal fluid management market is defined by some of the key factors, such as increasing incidences of CSF leak and growing developments for CSF management products. On the other hand, the risk associated with CSF shunts hinders the market growth.

The Canada Communicable Disease Report (CCDR), Centers for Disease Control and Prevention (CDC), European Union, Italian Trade Agency (ITA) are a few key primary and secondary sources referred to while preparing the report on the cerebrospinal fluid management market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cerebrospinal fluid management.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global cerebrospinal fluid management, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global cerebrospinal fluid management trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Cerebrospinal Fluid Management Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 North America PEST Analysis
  • 4.2.2 Europe PEST Analysis
  • 4.2.3 Asia Pacific PEST Analysis
  • 4.2.4 South & Central America PEST Analysis
  • 4.2.5 Middle East & Africa PEST Analysis

5. Cerebrospinal Fluid Management Market - Key Industry Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Incidences of CSF Leak
  • 5.1.2 Growing Developments for CSF Management Products
• 5.2 Market Restraints
  • 5.2.1 Risk Associated with CSF Shunts
• 5.3 Market Opportunities
  • 5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
• 5.4 Future Trends
  • 5.4.1 Technological Developments for CSF Shunts
• 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Global Market Analysis

• 6.1 Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

• 7.1 Overview
• 7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
• 7.3 CSF Shunts
  • 7.3.1 Overview
  • 7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3.3 Ventriculoperitoneal Shunts
    • 7.3.3.1 Overview
    • 7.3.3.2 Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3.4 Ventriculoatrial Shunts
    • 7.3.4.1 Overview
    • 7.3.4.2 Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3.5 Ventriculopleural Shunts
    • 7.3.5.1 Overview
    • 7.3.5.2 Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3.6 Lumboperitoneal Shunts
    • 7.3.6.1 Overview
    • 7.3.6.2 Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 CSF Drainage Systems
  • 7.4.1 Overview
  • 7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4.3 External Ventricular Drainage (EVD) Systems
    • 7.4.3.1 Overview
    • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4.4 Lumbar Drainage (LD) Systems
    • 7.4.4.1 Overview
    • 7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

• 8.1 Overview
• 8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
• 8.3 Hospitals
  • 8.3.1 Overview
  • 8.3.2 Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Clinics
  • 8.4.1 Overview
  • 8.4.2 Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Ambulatory Surgical Centers
  • 8.5.1 Overview
  • 8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Cerebrospinal Fluid Management Market - Geographical Analysis

• 9.1 North America Cerebrospinal Fluid Management Market, Revenue and Forecast To 2030
  • 9.1.1 Overview
  • 9.1.2 North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.1.2.1 North America Cerebrospinal Fluid Management Market, by Product
      • 9.1.2.1.1 North America Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.1.2.1.2 North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    • 9.1.2.2 North America Cerebrospinal Fluid Management Market, by End User
    • 9.1.2.3 North America Cerebrospinal Fluid Management Market, by Country
    • 9.1.2.4 US
      • 9.1.2.4.1 Overview
      • 9.1.2.4.2 US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.1.2.4.3 US Cerebrospinal Fluid Management Market, by Product
      • 9.1.2.4.3.1 US Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.1.2.4.3.2 US Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.1.2.4.4 US Cerebrospinal Fluid Management Market, by End User
    • 9.1.2.5 Canada
      • 9.1.2.5.1 Overview
      • 9.1.2.5.2 Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.1.2.5.3 Canada Cerebrospinal Fluid Management Market, by Product
      • 9.1.2.5.3.1 Canada Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.1.2.5.3.2 Canada Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.1.2.5.4 Canada Cerebrospinal Fluid Management Market, by End User
    • 9.1.2.6 Mexico
      • 9.1.2.6.1 Overview
      • 9.1.2.6.2 Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.1.2.6.3 Mexico Cerebrospinal Fluid Management Market, by Product
      • 9.1.2.6.3.1 Mexico Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.1.2.6.3.2 Mexico Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.1.2.6.4 Mexico Cerebrospinal Fluid Management Market, by End User
• 9.2 Europe Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
  • 9.2.1 Overview
  • 9.2.2 Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.2.2.1 Europe Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.1.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.1.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    • 9.2.2.2 Europe Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.3 Europe Cerebrospinal Fluid Management Market, by Country
    • 9.2.2.4 UK
      • 9.2.2.4.1 Overview
      • 9.2.2.4.2 UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.4.3 UK Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.4.3.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.4.3.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.4.4 UK Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.5 Germany
      • 9.2.2.5.1 Overview
      • 9.2.2.5.2 Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.5.3 Germany Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.5.3.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.5.3.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.5.4 Germany Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.6 France
      • 9.2.2.6.1 Overview
      • 9.2.2.6.2 France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.6.3 France Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.6.3.1 France Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.6.3.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.6.4 France Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.7 Italy
      • 9.2.2.7.1 Overview
      • 9.2.2.7.2 Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.7.3 Italy Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.7.3.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.7.3.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.7.4 Italy Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.8 Spain
      • 9.2.2.8.1 Overview
      • 9.2.2.8.2 Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.8.3 Spain Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.8.3.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.8.3.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.8.4 Spain Cerebrospinal Fluid Management Market, by End User
    • 9.2.2.9 Rest of Europe
      • 9.2.2.9.1 Overview
      • 9.2.2.9.2 Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.9.3 Rest of Europe Cerebrospinal Fluid Management Market, by Product
      • 9.2.2.9.3.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.2.2.9.3.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.9.4 Rest of Europe Cerebrospinal Fluid Management Market, by End User
• 9.3 Asia Pacific Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
  • 9.3.1 Overview
  • 9.3.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.3.2.1 Asia Pacific Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.1.2 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    • 9.3.2.2 Asia Pacific Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.3 Asia Pacific Cerebrospinal Fluid Management Market, by Country
    • 9.3.2.4 China
      • 9.3.2.4.1 Overview
      • 9.3.2.4.2 China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.4.3 China Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.4.3.1 China Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.4.3.2 China Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.4.4 China Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.5 Japan
      • 9.3.2.5.1 Overview
      • 9.3.2.5.2 Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.5.3 Japan Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.5.3.1 Japan Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.5.3.2 Japan Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.5.4 Japan Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.6 India
      • 9.3.2.6.1 Overview
      • 9.3.2.6.2 India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.6.3 India Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.6.3.1 India Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.6.3.2 India Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.6.4 India Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.7 Australia
      • 9.3.2.7.1 Overview
      • 9.3.2.7.2 Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.7.3 Australia Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.7.3.1 Australia Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.7.3.2 Australia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.7.4 Australia Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.8 South Korea
      • 9.3.2.8.1 Overview
      • 9.3.2.8.2 South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.8.3 South Korea Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.8.3.1 South Korea Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.8.3.2 South Korea Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.8.4 South Korea Cerebrospinal Fluid Management Market, by End User
    • 9.3.2.9 Rest of Asia Pacific
      • 9.3.2.9.1 Overview
      • 9.3.2.9.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.9.3 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by Product
      • 9.3.2.9.3.1 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.3.2.9.3.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.9.4 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by End User
• 9.4 Middle East & Africa Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
  • 9.4.1 Overview
  • 9.4.2 Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.4.2.1 Middle East & Africa Cerebrospinal Fluid Management Market, by Product
      • 9.4.2.1.1 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.4.2.1.2 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    • 9.4.2.2 Middle East & Africa Cerebrospinal Fluid Management Market, by End User
    • 9.4.2.3 Middle East & Africa Cerebrospinal Fluid Management Market, by Country
    • 9.4.2.4 UAE
      • 9.4.2.4.1 Overview
      • 9.4.2.4.2 UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.4.3 UAE Cerebrospinal Fluid Management Market, by Product
      • 9.4.2.4.3.1 UAE Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.4.2.4.3.2 UAE Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.4.4 UAE Cerebrospinal Fluid Management Market, by End User
    • 9.4.2.5 Saudi Arabia
      • 9.4.2.5.1 Overview
      • 9.4.2.5.2 Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.5.3 Saudi Arabia Cerebrospinal Fluid Management Market, by Product
      • 9.4.2.5.3.1 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.4.2.5.3.2 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.5.4 Saudi Arabia Cerebrospinal Fluid Management Market, by End User
    • 9.4.2.6 South Africa
      • 9.4.2.6.1 Overview
      • 9.4.2.6.2 South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.6.3 South Africa Cerebrospinal Fluid Management Market, by Product
      • 9.4.2.6.3.1 South Africa Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.4.2.6.3.2 South Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.6.4 South Africa Cerebrospinal Fluid Management Market, by End User
    • 9.4.2.7 Rest of Middle East & Africa
      • 9.4.2.7.1 Overview
      • 9.4.2.7.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.7.3 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by Product
      • 9.4.2.7.3.1 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.4.2.7.3.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.7.4 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by End User
• 9.5 South & Central America Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
  • 9.5.1 Overview
  • 9.5.2 South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.5.2.1 South & Central America Cerebrospinal Fluid Management Market, by Product
      • 9.5.2.1.1 South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.5.2.1.2 South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    • 9.5.2.2 South & Central America Cerebrospinal Fluid Management Market, by End User
    • 9.5.2.3 South & Central America Cerebrospinal Fluid Management Market, by Country
    • 9.5.2.4 Brazil
      • 9.5.2.4.1 Overview
      • 9.5.2.4.2 Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.2.4.3 Brazil Cerebrospinal Fluid Management Market, by Product
      • 9.5.2.4.3.1 Brazil Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.5.2.4.3.2 Brazil Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.5.2.4.4 Brazil Cerebrospinal Fluid Management Market, by End User
    • 9.5.2.5 Argentina
      • 9.5.2.5.1 Overview
      • 9.5.2.5.2 Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.2.5.3 Argentina Cerebrospinal Fluid Management Market, by Product
      • 9.5.2.5.3.1 Argentina Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.5.2.5.3.2 Argentina Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.5.2.5.4 Argentina Cerebrospinal Fluid Management Market, by End User
    • 9.5.2.6 Rest of South & Central America
      • 9.5.2.6.1 Overview
      • 9.5.2.6.2 Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.2.6.3 Rest of South & Central America Cerebrospinal Fluid Management Market, by Product
      • 9.5.2.6.3.1 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
      • 9.5.2.6.3.2 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.5.2.6.4 Rest of South & Central America Cerebrospinal Fluid Management Market, by End User

10. Pre & Post Covid-19 Impact

• 10.1 Pre & Post Covid-19 Impact

11. Cerebrospinal Fluid Management Market -Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Medtronic Plc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Integra LifeSciences Holdings Corp
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 B. Braun SE
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Argi Group Health Services Ltd Sti
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Sophysa SA
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 BeckerSmith Medical Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Delta Surgical Ltd
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Moller Medical GmbH
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Natus Medical Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Spiegelberg GmbH & Co KG
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms

관련자료